	polysorbate	8.955628237994146
	anaphylactic shock	3.7810449401020176
	taxane derivative	3.7728615006608286
	taxane composition	3.7501474806397206
	anaphylactic effect	3.7349024755695703
	perfusion stability	3.492199252946686
	reduced ethanol	3.266205992546977
	anaphylactic alcohol intoxication manifestation	3.1881520532934657
	surfactant Cremophor	2.5954109049599183
	intravenous infusion	1.8213815662039208
	R7	1.499201403665415
	tert	1.499201403665415
	aqueous infusion fluid	1.4307925383667754
¡°	chemotherapy cancer drug docetaxel	1.1981178562507453
	precipitation phenomenon	1.0294174339952853
¡°	Taxotere	0.9054755697311989
	hydroxy	0.9038453303967825
	butoxy	0.8647790085350675
	Docetaxel	0.7499326773862272
	Taxol	0.7499326773862272
	R6	0.7499326773862272
	cancer drug paclitaxel	0.7497009284883532
	order deadline	0.6023041268943397
	polyethoxylate castor oil	0.5538608309128084
	Tarr reference	0.49973637522611575
	Correction	0.43258099654424104
	R1	0.43258099654424104
	glucose	0.43258099654424104
	accuse product	0.4306538970432757
	eight hour stability limitation	0.3928419516655988
	physiological saline	0.39227245083511586
	solid clump	0.3810870085246284
	IPCom GmbH	0.3803526838273046
	additive	0.3752856134836919
	first two limitation	0.3582026031714343
	unsubstituted phenyl	0.34267573219099184
	injectable aqueous solution	0.3303331623444089
	hydrogen r5	0.3260646553403502
	injectable solution	0.313860858273042
	R3	0.3015485946899874
	R4	0.3015485946899874
	R2	0.3015485946899874
	Nutrition	0.3015485946899874
	diluted aqueous solution	0.28960152331014977
	stock solution	0.2879007572658727
	four hour	0.20624186493146765
	Iovate Health Scis	0.19559970495348455
	haec verba	0.1817146876192536
	sign	0.17004718299037783
	serious allergic reaction	0.1621951910139813
	Oral Argument	0.15702151868945863
	minimum stability	0.1535743214010036
	approximately hour	0.14061994414124415
	Bio Engineered Supplements	0.13940022246757156
	L.L.C.	0.1389961969258328
	least eight hour	0.12725811251831176
	CCS Fitness	0.10305018437746805
	low solubility	0.09287855523850248
	third solvent	0.08114780026746903
	Medrad	0.08089437880564072
	physical standpoint	0.07815450770315684
	clear limiting description	0.07630658900487232
	pleading	0.07362164697503823
	two solvent solution	0.05423835884010494
	manifest exclusion	0.0521774023903864
	reduced risk	0.047188626831870695
	Certificate	0.04625030178977365
	thirty minute	0.046241035976144276
	insight	0.04609450162123082
	Prost	0.04182079466807985
	prior art three solvent solution	0.03874319806540056
	appx	0.03808372101436227
	certain safety	0.03193126519939151
	stringent standard	0.030864551557962985
	efficacy standard	0.029330297608853282
	approximately mg ml	0.029169330366500802
	clear unmistakable disavowal	0.028067804996319147
	clear disavowal	0.02786881073525399
	withholding	0.02490928259929424
	inequitable conduct	0.024769576820911278
	formula	0.021535842961132045
	patient	0.01997250183324189
	restriction	0.019821531098464424
	additional efficacy	0.019619907203682143
	specification expression	0.019594054909610848
	clear expression	0.019523181620963146
	least active pharmaceutical ingredient	0.018228704571122217
	specifically enumerate limitation	0.017864874921742095
	lexicographer	0.017569515133142574
	specific intent	0.01745733279056333
	allegation	0.015932255717099747
	certain duration	0.013980472254000098
	Delaware	0.012241339663029704
	pto	0.011159745387286469
	Barr Labs. Inc.	0.010817404076569134
	ordinary accustomed meaning	0.010556759220461797
	i. BACKGROUND	0.009723679885600415
	Teleflex	0.009516594120389178
	compound	0.00839066427483193
	U.S. Food Drug Administration	0.006956203980046876
	water	0.006663396554378801
	patentee intention	0.005765076144447423
	patentee observation	0.004612350825448703
	ordinary customary meaning	0.004317690391006178
	neither exception	0.004303581758842822
	New Drug Application	0.004142901936121707
	plain language	0.0034223244350195608
	plain ordinary meaning	0.0030556125751271526
	bench trial	0.0030488518164958718
	FDA approval	0.0030096429335164363
	PTO	0.002781455544307597
	defense	0.0027573307862929835
	special definition	0.002399665754624426
	discretion	0.002295734692969238
	market generic version	0.002292557269104408
	specific characteristic	0.002113907701067808
	accordance	0.0019581937855583215
	treatment	0.0018619378190920096
	essential feature	0.0016752157822024357
	contrast	0.0008832234647444411
	specification discussion	0.0008212890470162637
	great weight	0.0005218637148830098
	II	0.0004870434093014802
	propose construction	0.0003792101947266721
	two circumstance	0.0003601239248374751
	embodiment	0.0002904713547066925
	nothing	0.0002519058809705511
	respect	0.0002509726927293929
	banc	0.0002420570982727634
	general description	0.00019641030369403978
	interpretation	0.0001628150747654423
	full scope	0.0001597843812054809
	otherwise broad term	0.00015437340361128396
	Patent Trademark Office	0.0001382576346894895
	prosecution history	0.0001165204119573629
	additional limitation	0.00011427162918286066
	district court construction	7.602606416207432e-05
	de novo	7.541198458680407e-05
	background	7.195517265709088e-05
	Claim	6.873468774141081e-05
	ordinary skill	5.7767803729482536e-05
	material	4.269758887898788e-05
	inventor	3.844474867954441e-05
	competitor motion	3.177948454103242e-05
	suit	3.082264486355389e-05
	jurisdiction	3.0516333481145985e-05
	two term	2.462098268141513e-05
	particular term	2.0890555091010122e-05
	favor	2.0433203530629852e-05
	disclose example	2.0343403995676544e-05
	particular limitation	2.012846382135769e-05
	dispute term	1.9938928797337534e-05
	analysis	1.4312867052582578e-05
	district court finding	1.3250750859242541e-05
	Idaho	6.698241230256882e-06
	light	3.0854318448317898e-06
	prior art reference	2.57400770741287e-06
	time	9.426372506988786e-07
	party	8.622262521781816e-08
	judgment	4.835173433025412e-09
	Corp.	2.4654283753861405e-09
	issue	9.887841177008148e-10
	District	0.0
	Court	0.0
	Appeals	0.0
	Fed	0.0
